Highlight brain imaging analysis solutions, including 'Neurophet AQUA AD', which monitors side effects from Alzheimer's disease treatments To accelerate partnering efforts with global pharmaceutical ...

Demonstrated brain imaging analysis solutions, including 'Neurophet AQUA AD,' which enables monitoring of adverse effects associated with Alzheimer's disease treatments Highlighted clinical cases that ...

Jake Junkil Been, Co-CEO of Neurophet said that "Neurophet AQUA AD is gaining attention as a collaborative partner among various Korean and international companies in the field of brain imaging ...

At the symposium, Neurophet operated an exhibition booth and showcased its major AI-powered brain imaging analysis solutions, including Neurophet AQUA AD, a software that supports monitoring of ...

At the conference, Neurophet showcased its software 'Neurophet AQUA AD,' which supports monitoring of Alzheimer's disease treatment prescription, therapeutic response, and potential adverse effects.